TESSA WEIGEL: Open Payments
NPI 1073995353 · NORTH KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 74 payments from 12 companies in 2025. Trend: 2023 $1,165 · 2024 $1,041 · 2025 $1,263
Food & beverage: $1,263
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 22 | $363 |
| Calliditas Therapeutics US Inc. | 10 | $246 |
| Novartis Pharmaceuticals Corporation | 7 | $163 |
| Travere Therapeutics, Inc. | 18 | $156 |
| AstraZeneca Pharmaceuticals LP | 6 | $102 |
| OPKO Pharmaceuticals, LLC | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| AKEBIA THERAPEUTICS INC | 2 | $38 |
| Fresenius USA Marketing, Inc. | 2 | $36 |
| Ardelyx, Inc. | 1 | $23 |
Products named: Kerendia, TARPEYO, Fabhalta, LOKELMA, RAYALDEE, BENLYSTA, Vafseo, VELPHORO.
Industry payments across MO — which companies pay providers there.
